Lv31
260 积分 2024-05-30 加入
A Bioorthogonal Prodrug–Prodrug Strategy for Dual Activation Via Retro-Cope/Cope Elimination
17天前
已完结
High-concentration biologic formulations: challenges, strategies, and emerging technologies for subcutaneous delivery
1个月前
已完结
Selection of Payloads for Antibody–Drug Conjugates Targeting Ubiquitously Expressed Tumor-Associated Antigens: a Case Study
1个月前
已完结
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD
1个月前
已完结
Pharmacokinetics and Safety Study of HN0037, a Novel Anti‐Human Herpes Simplex Virus Inhibitor, in Healthy Volunteers
2个月前
已完结
Clinical and Molecular Genetics of the Phosphodiesterases (PDEs)
2个月前
已完结
Development of APH003─a Highly Potent, Selective, and Orally Bioavailable IRAK4 PROTAC Degrader for the Treatment of Inflammatory Diseases
3个月前
已完结
Current and Emerging Prodrug Strategies
3个月前
已完结
Male premating treatment in FEED studies: Length is not everything
4个月前
已完结
皖公网安备34019202002308
